ANTIDEPRESSANT-LIKE EFFECTS OF DOPAMINE AGONISTS IN AN ANIMAL-MODEL OF DEPRESSION

被引:93
作者
MUSCAT, R [1 ]
PAPP, M [1 ]
WILLNER, P [1 ]
机构
[1] CITY LONDON POLYTECH,DEPT PSYCHOL,OLD CASTLE ST,LONDON E1 7NT,ENGLAND
基金
英国医学研究理事会;
关键词
D O I
10.1016/0006-3223(92)90119-K
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Chronic exposure to mild unpredictable stress (CMS) has previously been found to cause an antidepressant-reversible decrease in the consumption of palatable sweet solutions. There is evidence that the effect of antidepressants in this model is mediated by an increase in transmission at dopamine (DA) synapses. The present study investigated whether another treatment known to increase the functional responsiveness of DA systems, intermittent administration of DA agonists, would have antidepressant-like effects. In three experiments in rats, CMS-induced decreases in sucrose consumption were reversed by three to four twice-weekly injections of quinpirole (100-200-mu-g/kg) or bromocriptine (2.5 mg/kg). The effects lasted for several weeks, and when they waned, could be reinstated by a single additional injection of quinpirole. As with tricyclic antidepressants, the effect of quinpirole was reversed by raclopride, administered acutely immediately prior to a sucrose consumption test; there were no changes in sucrose intake in nonstressed control animals. The results suggest that intermittent administration of DA agonists merits investigation as a novel strategy for the treatment of depression.
引用
收藏
页码:937 / 946
页数:10
相关论文
共 37 条
  • [1] ADLERMW, 1990, TESTING EVALUATION D
  • [2] [Anonymous], 1971, STAT PRINCIPLES EXPT
  • [3] Bozarth M. A., 1987, METHODS ASSESSING RE
  • [4] POTENTIAL NEUROLEPTIC AGENTS .4. CHEMISTRY, BEHAVIORAL PHARMACOLOGY, AND INHIBITION OF [H-3] SPIPERONE BINDING OF 3,5-DISUBSTITUTED N-[(1-ETHYL-2-PYRROLIDINYL)METHYL]-6-METHOXYSALICYLAMIDES
    DEPAULIS, T
    KUMAR, Y
    JOHANSSON, L
    RAMSBY, S
    HALL, H
    SALLEMARK, M
    ANGEBYMOLLER, K
    OGREN, SO
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (01) : 61 - 69
  • [5] FAWCETT J, 1983, ARCH GEN PSYCHIAT, V40, P79
  • [6] JIMERSON DC, 1987, PSYCHOPHARMACOLOGY 3, P515
  • [7] EFFECTS OF GBR-12909, A SELECTIVE DOPAMINE UPTAKE INHIBITOR, ON MOTOR-ACTIVITY AND OPERANT-BEHAVIOR IN THE RAT
    KELLEY, AE
    LANG, CG
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 167 (03) : 385 - 395
  • [8] Liebman J. M, 1989, NEUROPHARMACOLOGICAL
  • [9] MAJ J, 1990, DOPAMINE MENT DEPRES, P139
  • [10] MARTINIVERSON MT, 1988, PSYCHOPHARMACOLOGY, V95, P534